Enhancing Heart Allograft Function With the OCS Heart System Trial
TransMedics · NCT07145515
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 655
- US sites recruiting
- 7
- Study start
- January 2026
- Record last updated
- January 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution and OFE compared to Static Cold Storage (SCS) in DBD heart transplantation to potentially demonstrate superiority.
Being studied: OCS Heart; Static Cold Storage (SCS)
Conditions: Heart Transplant
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Part A - DCD Donor Hearts \& DBD Donor Hearts Initially Deemed Unsuitable for Cold Storage (Current Approved Indications):
Donor Inclusion Criteria
- Donor hearts are deemed clinically acceptable for transplantation after physical examination of the donor hearts in the donor chest and/or on the back table in the donor operating room.
- All DCD donors eligible for functional warm ischemic time criteria ≤ 30 minutes. WIT defined as time from when mean systolic blood pressure (SBP) is \<50mmHg (sustained for at least 5 minutes) to aortic cross clamp and administration of old cardioplegia in the donor.
- DBD donor hearts with an expected cross clamp of ≥ 4 hours
- DBD donor hearts with any of the following organ quality concerns, regardless of cross clamp time:
- Donor age ≥ 40 years old
- Unknown downtime
- Insignificant CAD
- LVEF ≤ 50%
Donor Exclusion • Moderate to severe aortic incompetence
Part B - DBD Donor Hearts Currently Used with Cold Storage (New Indication):
Donor Inclusion Criteria
- Donor hearts are deemed clinically acceptable for transplantation after physical examination of the donor hearts in the donor chest and/or on the back table in the donor operating room.
- Eligible for randomization to OCS or SCS treatment arms.
- DBD donor hearts with an expected cross clamp time of \< 4 hours.
Donor Exclusion
- Moderate to severe aortic incompetence
- DBD donor with any of the following organ quality concerns:
- Donor age ≥ 40 years old
- Unknown downtime
- Insignificant CAD
- LVEF ≤ 50%
Recipient Eligibility Criteria (for Part A and B Cohorts)
Inclusion
- Signed informed consent document and authorization to use and disclose protected health information
- Heart transplant candidate
- Age ≥ 18 years old
Exclusion
- Participant in any other interventional clinical or investigational trials/programs that may confound the outcomes of this trial
Recruiting US locations
University of California San Francisco
San Francisco, CA 94143
Site contact: Imani Dunn · Imani.Robinson@ucsf.edu
Tampa General Hospital
Tampa, FL 33606
Site contact: Courtney Nicholas · 813-844-4914 · courtneynicholas@tgh.org
Massachusetts General Hospital
Boston, MA 02114
Site contact: Kamila Drezek · KDREZEK@mgh.harvard.edu
Mount Sinai
New York, NY 10029
Site contact: Favio Herbas · Favio.Herbas@mountsinai.org
Westchester Medical Center
Valhalla, NY 10595
Site contact: Corazon De La Pena · 914-493-2483 · Corazon.Delapena@wmchealth.org
Duke University
Durham, NC 27710
Site contact: Sarah Casalinova · 919-613-5621 · sarah.casalinova@duke.edu
Baylor Scott and White
Dallas, TX 75226
Site contact: Lesia Parker
Study contacts (from the official record)
- Raicca Haqqi · 978-809-0620 · rhaqqi@transmedics.com
- Kausar Qidwai · 978-494-7105 · kqidwai@transmedics.com